1st Guideline of atherosclerosis prevention in childhood and adolescence;I diretriz de prevenção da aterosclerose na infância e na adolescência

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue SUPPL. 6, 2005, Pages

  Back Giuliano, Isabela De Carlos ^a   Caramelli, Bruno ^a   Pellanda, Lucia ^a   Duncan, Bruce ^a   Mattos, Sandra ^a,a   Fonseca, Francisco H ^a,a   Pereira, Abel ^a   Neto, Abrahão Afiune ^a   Forti, Adriana ^a   Costa, Alessandra ^a   Macedo, Alessandra ^a   Raupp, Aline ^a   Chacra, Ana Paula ^a   Brandão, Andrea ^a   Loures Vale, Andréia A ^a   Scherr, Carlos ^a   Amodeo, Celso ^a   Blanco, Danielle M ^a   Vargas, Deisi M ^a   Moriguchi, Emilio ^a   Ceragioli Oliveira, Fernanda Luisa ^a   Costa, Geodete ^a   Xavier, Hermes Toros ^a   Chaves, Hilton ^a   Cintra, Isa De Pádua ^a   Guimarães, Isabel ^a   Giuliano, Isabela ^a   Rivera, Ivan ^a   Diament, Jayme ^a   Saraiva, José Francisco ^a   Zaguri, Leão ^a   Bricarello, Liliana ^a   Martinez, Lilton C ^a   Tambascia, Marcos ^a   Mendonça Silva, Maria Alayde ^a   Schmith Escrivão, Maria Arlete Meil ^a   Izar, Maria C O ^a   Roiseman, Maria M L ^a   De Souza Pires, Maria Marlene ^a   Lipp, Marilda ^a   Obelar, Marileise ^a   Coutinho, Mario ^a   Silva, Mauricio Laerte ^a   Fisberg, Mauro ^a   Forti, Neusa ^a   E Silva, Odwaldo Barbosa ^a   Monte, Osmar ^a   Nazário, Rafaella ^a   Dos Santos, Raul Dias ^a   Da Costa Ribeiro, Robespierre Queiroz ^a   Costa, Rosana Perim ^a   Patin, Rose Vega ^a   Sarni, Roseli ^a   Fernandes, Sidney ^a   Reichert, Simone ^a   Martinez, Tania ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMLODIPINE; ATENOLOL; ATORVASTATIN; BENAZEPRIL; CAPTOPRIL; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; DOXAZOSIN; ENALAPRIL; EZETIMIBE; FELODIPINE; FIBRIC ACID DERIVATIVE; FOSINOPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; MEVINOLIN; NIFEDIPINE; PRAVASTATIN; PRAZOSIN; PROPRANOLOL; QUINAPRIL; SIMVASTATIN; UNINDEXED DRUG;

ADOLESCENT DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CHOLESTEROL METABOLISM; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; GENETIC ASSOCIATION; HUMAN; LIFESTYLE; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; RISK REDUCTION; SEX DIFFERENCE;

EID: 31144434643     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. Arq Bras Cardiol 2004; 83(5):429-33.
2. Fuchs SC, Petter JG, Accordi MC, Zen VL, Pizzol AD, Jr., Moreira LB et al. Establishing the prevalence of hypertension. Influence of sampling criteria. Arq Bras Cardiol 2001; 76(6):445-52.
3. IBGE. Pesquisa de Orçamentos Familiares - POF 2002-2003. http://www.ibge.gov.br/home/presidencia/noticias/noticia_impressao.php? id_noticia=278. 10-10-2005.
4. Silva MA, Rivera IR, Ferraz MR, Pinheiro AJ, Alves SW, Moura AA et al. Prevalência de fatores de risco cardiovascular em crianças e adolescentes da rede de ensino da cidade de Maceió. Arq Bras Cardiol 2005; 84(5):387-392.
5. da Silva RC, Malina RM. Prevalência e fatores associado ao sedentarismo em adolescentes de área urbana. Cad Saude Publica 2000; 16(4):1091-1097.
6. Moura EC, de Castro CM, Mellin AS, de Figueiredo DB. Perfil lipídico em escolares de Campinas,SP,Brasil. Rev Saude Publica 2000; 34(5):499-505.
7. Giuliano IC, Coutinho MS, Freitas SF, Pires MM, Zunino JN, Ribeiro RQ. Lípides séricos em crianças e adolescentes da rede escolar de Florianópolis - Estudo Floripa Saudável 2040. Arq Bras Cardiol 2005; 85(2):85-91.
8. Bordin R, Nipper VB, Silva JO, Bortolomiol L. Prevalência de tabagismo entre escolares em municípios de área metropolitana da região Sul, Brasil, 1991. Cad Saude Publica 1993; 9(2):185-189.
9. Levantamento sobre o uso de drogas entre estudantes de 1° e 2° graus em 10 capitais brasileiras. Centro Brasileiro de Informações sobre Drogas Psicotrópicas (CEBRID), editor. 1997. 1997.
10. IBGE. Tendências Demográficas. Uma análise dos resultados da amostra do censo demográfico 2000. http://www.datasus.br/. 10-10-2005. Ministério do Planejamento,Orçamento e Gestão.
11. Batista Filho M, Rissin A. A transição nutricional no Brasil - tendências regionais e temporais. Caderno de Saúde Pública 2003; 19(suppl 1):181-91.
12. Mendonca CP, dos Anjos LA. Aspectos das práticas alimentares e da atividade física como determinantes do crescimento do sobrepeso/obesidade no Brasil. Cad Saude Publica 2004; 20(3):698-709.
13. Abrantes MM, Lamounier JA, Colosimo EA. Prevalência de sobrepeso e obesidade em crianças e adolescentes das regiões Sudeste e Nordeste. J Pediatr (Rio J) 2002; 78(4):335-40.
14. Barker DJ, Hanson MA. Altered regional blood flow in the fetus: the origins of cardiovascular disease? Acta Paediatr 2004; 93(12):1559-60.
15. Barker DJ. In utero programming of cardiovascular disease. Theriogenology 2000; 53(2):555-74.
16. Barker DJ. Fetal origins of coronary heart disease. Bmj 1995; 311(6998):171-4.
17. Barker DJ, Martyn CN, Osmond C, Wield GA. Abnormal liver growth in utero and death from coronary heart disease. Bmj 1995; 310(6981):703-4.
18. Wintour EM, Johnson K, Koukoulas I, Moritz K, Tersteeg M, Dodic M. Programming the cardiovascular system, kidney and the brain - a review. Placenta 2003; 24 Suppl A:65-71.
19. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353(9166):1789-92.
20. de Onis M, Blossner M, Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur J Clin Nutr 1998; 52 Suppl 1:5-15.
21. Meshari AA, De Silva S, Rahman I. Fetal macrosomia - maternal risks and fetal outcome. Int J Gynaecol Obstet 1990; 32(3):215-22.
22. Pribylova H, Dvorakova L. Long-term prognosis of infants of diabetic mothers. Relationship between metabolic disorders in newborns and adult offspring. Acta Diabetol 1996; 33(1):30-4.
23. Merzouk H, Bouchenak M, Loukidi B, Madani S, Prost J, Belleville J. Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition. J Clin Pathol 2000; 53(12):917-23.
24. Merzouk H, Madani S, Prost J, Loukidi B, Meghelli-Bouchenak M, Belleville J. Changes in serum lipid and lipoprotein concentrations and compositions at birth and after 1 month of life in macrosomic infants of insulin-dependent diabetic mothers. Eur J Pediatr 1999; 158(9):750-6.
25. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE et al. Birth weight and adult hypertension and obesity in women. Circulation 1996; 94(6):1310-5.
26. Fowden AL. The role of insulin in prenatal growth. J Dev Physiol 1989; 12(4):173-82.
27. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31(6):1235-9.
28. Lawlor DA, Davey Smith G, Ebrahim S. Birth weight is inversely associated with coronary heart disease in post-menopausal women: findings from the British women's heart and health study. J Epidemiol Community Health 2004; 58(2):120-5.
29. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. Faseb J 2002; 16(11):1348-60.
30. Walker SP, Gaskin P, Powell CA, Bennett FI, Forrester TE, Grantham-McGregor S. The effects of birth weight and postnatal linear growth retardation on blood pressure at age 11-12 years. J Epidemiol Community Health 2001; 55(6):394-8.
31. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet 2001; 357(9254):413-9.
32. Fall CH, Stein CE, Kumaran K, Cox V, Osmond C, Barker DJ et al. Size at birth, maternal weight, and type 2 diabetes in South India. Diabet Med 1998; 15(3):220-7.
33. Gillman MW, Rifas-Shiman SL, Camargo CA, Jr., Berkey CS, Frazier AL, Rockett HR et al. Risk of overweight among adolescents who were breastfed as infants. Jama 2001; 285(19):2461-7.
34. Li L, Parsons TJ, Power C. Breast feeding and obesity in childhood: cross sectional study. Bmj 2003; 327(7420):904-5.
35. Dietz WH. Breastfeeding may help prevent childhood overweight. Jama 2001; 285(19):2506-7.
36. Roberts SB. Prevention of hypertension in adulthood by breastfeeding? Lancet 2001; 357(9254):406-7.
37. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003; 168(1):1-14.
38. Bertolini S, Pisciotta L, Di Scala L, Langheim S, Bellocchio A, Masturzo P et al. Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 2004; 174(1):57-65.
39. Tracy RE, Newman WP3, Wattigney WA, Berenson GS. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci 1995; 310 Suppl 1:37-41.
40. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995; 41(10):1414-20.
41. Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995; 41(10):1421-6.
42. Pichet G, Lopes LM, Cotrim FLS, Scartezini M, Lima JCC, Martinez TLR. Lípides e lipoproteínas: interpretação dos dados laboratoriais e metodologias. In: Martinez TLR, editor. Condutas clínicas nas Dislipidemias. Belo Horizonte: Health, 1997: 85-115.
43. Santos RD. III Diretrizes Brasileiras sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001; 77 Suppl 3:1-48.
44. Branchi A, Rovellini A, Fiorenza AM, Torri A, Prandi W, Tomella C et al. Estimation of cardiovascular risk: total cholesterol versus lipoprotein profile. Int J Clin Lab Res 1994; 24(2):106-12.
45. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499-502.
46. Rifai N, Merrill JR, Holly RG. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Ann Clin Biochem 1990; 27 ( Pt 5):489-93.
47. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001; 285(19):2486-97.
48. Lichtenstein AH, Deckelbaum RJ. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001; 103(8):1177-9.
49. Brotons C, Ribera A, Perich RM, Abrodos D, Magana P, Pablo S et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis 1998; 139(1):1-9.
50. Ribeiro RQ. Epidemiologia das dislipidemias em escolares. Universidade Federal de MInas Gerais, 2000.
51. Morrison JA, Sprecher DL, Biro FM, Apperson-Hansen C, Dipaola LM. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrations. Metabolism 2002; 51(4):432-437.
52. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 2001; 50(11):2444-2450.
53. Hoffman RP, Vicini P, Sivitz WI, Cobelli C. Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res 2000; 48(3):384-388.
54. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995; 80(1):172-178.
55. Yamagishi SI, Edelstein D, Du XL, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001; 50(6):1491-1494.
56. Meier M, King GL. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med 2000; 5(3):173-185.
57. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001; 86(2):713-718.
58. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115(4):e500-e503.
59. Brandao AP, Brandao AA, Araujo EM. The significance of physical development on the blood pressure curve of children between 6 and 9 years of age and its relationship with familial aggregation. J Hypertens Suppl 1989; 7(1):S37-S39.
60. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(2 Suppl 4th Report):555-576.
61. Lurbe E, Sorof JM, Daniels SR. Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr 2004; 144(1):7-16.
62. Guimaraes JI, Gomes MA, Mion D, Jr., Nobre F, Mendonca MA, Cruz LL et al. III Diretrizes Brasileiras para MAPA/MRPA. Arq Bras Cardiol 2003; 80(2):225-233.
63. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111(1):61-66.
64. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20(5):1251-1260.
65. Daniels SR, Meyer RA, Liang YC, Bove KE. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 1988; 12(3):703-708.
66. Arnett DK, Glasser SP, McVeigh G, Prineas R, Finklestein S, Donahue R et al. Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study. Am J Hypertens 2001; 14(3):200-205.
67. Sinaiko AR, Gomez-Marin O, Prineas RJ. Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension 1993; 21(6 Pt 2):989-994.
68. Berenson GS, Srinivasan SR, Hunter SM, Nicklas TA, Freedman DS, Shear CL et al. Risk factors in early life as predictors of adult heart disease: the Bogalusa Heart Study. Am J Med Sci 1989; 298(3):141-51.
69. Campbell PT, Katzmarzyk PT, Malina RM, Rao DC, Perusse L, Bouchard C. Stability of adiposity phenotypes from childhood and adolescence into young adulthood with contribution of parental measures. Obes Res 2001; 9(7):394-400.
70. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 2001; 108(3):712-718.
71. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350(23):2362-2374.
72. Lima SC, Arrais RF, Almeida MG, Souza ZM, Pedrosa LF. Perfil lipídico e peroxidação de lipídeos no plasma em crianças e adolescentes com sobrepeso e obesidade. J Pediatr (Rio J) 2004; 80(1):23-28.
73. Glowinska B, Urban M, Koput A, Galar M. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis 2003; 167(2):275-286.
74. Freedman DS. Clustering of coronary heart disease risk factors among obese children. J Pediatr Endocrinol Metab 2002; 15(8):1099-1108.
75. Haszon I, Papp F, Kovacs J, Bors M, Nemeth I, Bereczki C et al. Platelet aggregation, blood viscosity and serum lipids in hypertensive and obese children. Eur J Pediatr 2003; 162(6):385-390.
76. Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD. Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol 2004; 19(12):1379-1384.
77. Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics 2004; 113(2):328-333.
78. Uiterwaal CS, Witteman JC, de Bruijn AM, Hofman A, Grobbee DE. Families and natural history of lipids in childhood: an 18-year followup study. Am J Epidemiol 1997; 145(9):777-785.
79. Clinical Growth Charts. http://www.cdc.gov/nchs/about/major/ nhanes/growthcharts/clinical_charts.htm. 2004. CDC-NCHS. 10-11-2005.
80. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002; 106(1):143-60.
81. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr 1994; 124(11 Suppl):2245S-2317S.
82. Goran MI, Kaskoun M, Johnson R. Determinants of resting energy expenditure in young children. J Pediatr 1994; 125(3):362-367.
83. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003; 107(11):1562-1566.
84. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94(4):857-862.
85. Physical fitness and activity in schools. American Academy of Pediatrics. Pediatrics 2000; 105(5):1156-1157.
86. Maron BJ, Chaitman BR, Ackerman MJ, Bayes dL, Corrado D, Crosson JE et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109(22):2807-2816.
87. Berenson GS, Srinivasan SR, Bao W, Newman WP, III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338(23):1650-1656.
88. Ball EJ, O'Connor J, Abbott R, Steinbeck KS, Davies PS, Wishart C et al. Total energy expenditure, body fatness, and physical activity in children aged 6-9 y. Am J Clin Nutr 2001; 74(4):524-528.
89. IBGE. Dados populacionais. http://www.ibge.gov.br. 8-10-2005. 10-10-2005.
90. INCA. Tabagismo. www.inca.gov.br/tabagismo. 2005. 10-10-2005.
91. Batra V, Patkar AA, Berrettini WH, Weinstein SP, Leone FT. The genetic determinants of smoking. Chest 2003; 123(5):1730-1739.
92. Comorbidade psiquiátrica em tabagismo. 00; III Simpósio internacional sobre o tratamento do tabagismo, 2005.
93. Jin C, Rossignol AM. Effects of passive smoking on respiratory illness from birth to age eighteen months, in Shanghai, People's Republic of China. J Pediatr 1993; 123(4):553-558.
94. Hanson K, Allen S, Jensen S, Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res 2003; 5(4):515-526.
95. Romaldini CC, Issler H, Cardoso AL, Diament J, Forti N. Fatores de risco para aterosclerose em crianças e adolescentes com história familiar de doença arterial coronariana prematura. J Pediatr (Rio J)2004; 80(2):135-140.
96. Beck A, Freeman A. Cognitive therapy of personality disorders. New York: Gulford Press, 1990.
97. Lipp MEN. Como enfrentar o estresse infantil. São Paulo: Cortez, 1991.
98. Steptoe A, Marmot M. Burden of psychosocial adversity and vulnerability in middle age: associations with biobehavioral risk factors and quality of life. Psychosom Med 2003; 65(6):1029-1037.
99. Jennings JR, Kamarck TW, Everson-Rose SA, Kaplan GA, Manuck SB, Salonen JT. Exaggerated blood pressure responses during mental stress are prospectively related to enhanced carotid atherosclerosis in middle-aged Finnish men. Circulation 2004; 110(15):2198-2203.
100. Calais SL, Andrade LB. Diferenças de sexo e escolaridade na manifestação de stress em adultos jovens. Psicologia Reflexão e Crítica, Rio Grande do Sul 2003; 16(2):257-263.
101. Lipp MEN. Crianças estressadas: sintomas, causas e soluções. Campinas: Papirus, 2003.
102. Tonstad S. A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits. Drug Saf 1997; 16(5):330-341.
103. Tonstad S. Role of lipid-lowering pharmacotherapy in children. Paediatr Drugs 2000; 2(1):11-22.
104. Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child 1996; 74(2):157-160.
105. Xydakis AM, Guyton JR, Chiou P, Stein JL, Jones PH, Ballantyne CM. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. Am J Cardiol 2004; 94(6):795-797.
106. Gagne C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002; 105(21):2469-2475.
107. Salen G, von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004; 109(8):966-71.
108. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344(1):3-10.
109. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens 1995; 8(7):657-665.
110. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35(2):544-549.
111. Kelley GA, Kelley KS, Tran ZV. The effects of exercise on resting blood pressure in children and adolescents: a meta-analysis of randomized controlled trials. Prev Cardiol 2003; 6(1):8-16.
112. Benavides S, Striet J, Germak J, Nahata MC. Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus. Pharmacotherapy 2005; 25(6):803-809.
113. Dao HH, Frelut ML, Oberlin F, Peres G, Bourgeois P, Navarro J. Effects of a multidisciplinary weight loss intervention on body composition in obese adolescents. Int J Obes Relat Metab Disord 2004; 28(2):290-299.
114. Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. Jama 2005; 293(23):2873-2883.
115. Godoy-Matos A, Carraro L, Vieira A, Oliveira J, Guedes EP, Mattos L et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005; 90(3):1460-1465.
116. Joffe A. Pharmacotherapy for adolescent obesity: a weighty issue. Jama 2005; 293(23):2932-2934.